Q-Bank Breakdown: Buspirone — Why Every Answer Choice Matters

You’re cruising through a question block, you see generalized anxiety, and your brain auto-clicks benzodiazepine. Then the stem adds: “history of alcohol use disorder” and “needs something for long-term control.” Now it’s not a reflex question—it’s a distractor discipline question. Buspirone is a classic Step anxiolytic that’s easy to recognize only if you know what it does and what it doesn’t do.

The Vignette (USMLE-Style)

A 32-year-old woman comes to clinic for “constant anxiety” for the past 9 months. She worries about work, finances, and her parents’ health “most days,” and she finds it difficult to control. She reports restlessness, muscle tension, and poor sleep. She denies panic attacks. She has no history of mania. She previously had an alcohol use disorder but has been sober for 2 years. Vitals are normal. She asks for a medication that won’t be sedating and won’t be addictive. Which of the following is the most appropriate pharmacotherapy?

A. Buspirone
B. Alprazolam
C. Propranolol
D. Bupropion
E. Phenelzine

---

First: Identify the Diagnosis

This is generalized anxiety disorder (GAD):

• Excessive anxiety and worry occurring more days than not for $\ge 6$ months
• Difficult to control
• Associated symptoms (classically: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance)

No episodic surges = not panic disorder. No trauma trigger cluster = not PTSD. No obsessions/compulsions = not OCD.

---

Correct Answer: Buspirone (A)

Why it’s correct

Buspirone is a strong “Step-style” answer when you need:

• Non-sedating long-term treatment for GAD
• No dependence / no withdrawal risk
• A good option when substance use history makes benzodiazepines a bad idea

Mechanism (high yield)

• Partial agonist at 5-HT$_{1A}$ receptors (serotonergic)
• Also has some dopamine effects (minor for Step-level)

Clinical pearls USMLE loves

• Indication: primarily GAD (not great for acute panic)
• Onset: delayed—typically 1–2 weeks (sometimes longer)
• No CNS depression like benzos (minimal sedation)
• No respiratory depression, no anticonvulsant properties, no muscle relaxant effect
• No tolerance, no dependence, no withdrawal
• Can be used as augmentation with SSRIs/SNRIs in some cases

Side effects to remember

• Dizziness, headache, nausea
• Not notable for sexual dysfunction like SSRIs (often a comparative advantage)

Bottom line: GAD + wants non-addictive + not sedating + substance use history → buspirone.

---

Distractor Autopsy: Why Each Wrong Choice Is Wrong

B. Alprazolam (benzodiazepine)

Why it tempts you: fast relief of anxiety symptoms.

Why it’s wrong here:

• High abuse potential—especially in someone with a history of substance use disorder
• Dependence and withdrawal risk (withdrawal can cause seizures)
• Causes sedation, psychomotor impairment, and can worsen falls/accidents
• Not ideal as long-term monotherapy for chronic GAD in Step-world framing

High-yield benzo facts

• MOA: increases frequency of GABA$_A$ channel opening
• Used for: acute anxiety, status epilepticus, alcohol withdrawal, muscle spasm
• Dangerous combo: benzos + opioids/alcohol → respiratory depression (synergistic)

---

C. Propranolol (nonselective $\beta$-blocker)

Why it tempts you: anxiety with physical symptoms.

Why it’s wrong here:

• Best for performance anxiety (e.g., public speaking), where tremor, palpitations are prominent
• This stem is chronic, diffuse worry for months—classic GAD, not stage fright

High-yield

• Helps somatic symptoms (tachycardia, tremor), not the core cognitive worry
• Contraindications: asthma/COPD (bronchospasm), bradycardia, some heart block

---

D. Bupropion

Why it tempts you: “a non-sedating antidepressant.”

Why it’s wrong here:

• Bupropion is activating and can worsen anxiety
• It’s used for MDD, smoking cessation, and sometimes ADHD off-label—not first-line for GAD

High-yield

• MOA: NDRI (norepinephrine/dopamine reuptake inhibitor)
• Side effects: lowers seizure threshold, insomnia, dry mouth
• No sexual dysfunction is a plus in depression—but not the move for primary anxiety

---

E. Phenelzine (MAOI)

Why it tempts you: “works for anxiety when others fail.”

Why it’s wrong here:

• MAOIs are not first-line due to safety and dietary/drug interaction burden
• Reserved for treatment-resistant depression and sometimes refractory anxiety disorders
• This patient is outpatient, stable, and asking for something safe and non-addictive—MAOI is the opposite vibe

High-yield MAOI toxicity & interactions

• Hypertensive crisis with tyramine (aged cheeses, cured meats, certain wines)
• Serotonin syndrome if combined with serotonergic agents (SSRIs/SNRIs/TCAs, linezolid, triptans, etc.)
• Requires washout periods when switching antidepressants

---

Step-Level Takeaway Table

---

Rapid-Fire High-Yield Buspirone Facts (What Q-Banks Love)

• Drug class: anxiolytic (non-benzodiazepine)
• MOA: partial agonist at 5-HT$_{1A}$
• Indication: GAD
• Not useful for: acute panic attacks, alcohol withdrawal, seizure control
• Onset: delayed (counsel patients—otherwise they think it “doesn’t work”)
• Advantages: minimal sedation, no dependence/withdrawal, safer in SUD history
• Common side effects: dizziness, headache, nausea

---

How to Lock In the Correct Choice in 5 Seconds

When you see:

• Chronic worry $\ge 6$ months + muscle tension/sleep issues = GAD
• Patient wants non-sedating and non-addictive
• History of substance use disorder

→ Buspirone should jump to the top of your list.